Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer

被引：0
|
作者：
John, Catherine [1 ]
Shen, Xiaochang [1 ]
Deng, Boer [1 ]
Zhao, Ziyi [1 ]
Zhou, Chunxiao [1 ]
Bae-Jump, Victoria [1 ]
Secord, Angeles Alvarez [2 ]
Batinic-Haberle, Ines [2 ]
Spasojevic, Ivan [2 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Duke Univ, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
043
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [1] Onvansertib exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer
    Sinha, Nikita
    Shen, Xiaochang
    Haag, Jennifer
    Chen, Shuning
    Emanuele, Michael
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S457 - S458
  • [2] Oleic acid, a monounsaturated fatty acid, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer
    Newton, Meredith
    Suo, Hongyan
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S140 - S140
  • [3] Ipatasertib, an oral AKT inhibitor, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    O'Donnell, Jillian
    Buckingham, Lindsey
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S41 - S42
  • [4] Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S31 - S31
  • [5] Ascorbate exhibits anticancer effects in pre-clinical models of serous endometrial cancer cells
    Sinha, Nikita
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Spasojevic, Ivan
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S210 - S211
  • [6] Sulindac, a COX1/COX2 inhibitor, exhibits anti-tumorigenic effects in obesity-driven models of endometrioid endometrial cancer
    John, Catherine
    Zhao, Ziyi
    Shen, Xiaochang
    Deng, Boer
    Strauss, Isabella
    Zhou, Chunxiao
    Sherman, Mark
    Hursting, Stephen
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S309 - S309
  • [7] SPR 064, a highly soluble taxane, exhibits anti-tumorigenic effects in endometrial cancer
    Staley, A.
    Tucker, K.
    Fan, Y.
    Zhao, X.
    Yin, Y.
    Fang, Z.
    Sun, W.
    Sen, S.
    Dugar, S.
    Zhang, Y.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 48 - 48
  • [8] Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
    O'donnell, Jillian
    Zhao, Ziyi
    Buckingham, Lindsey
    Hao, Tianran
    Suo, Hongyan
    Zhang, Xin
    Fan, Yali
    John, Catherine
    Deng, Boer
    Shen, Xiaochang
    Sun, Wenchuan
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria L. L.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (03)
  • [9] Palmitic acid, a common long-chain saturated fatty acid, demonstrates anti-proliferative and anti-tumorigenic effects in pre-clinical models of endometroid endometrial cancer
    Burkett, Wesley
    Zhao, Ziyi
    Newton, Meredith
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S140 - S140
  • [10] Ipatasertib, an oral AKT inhibitor, in combination with paclitaxel exhibits anti-proliferative and anti-tumorigenic effects in preclinical studies for endometrioid endometrial cancer: Endometrial cancer molecularly targeted therapy consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S125 - S126
12345